Financial Advocates Investment Management Sells 94 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Financial Advocates Investment Management lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.3% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 1,666 shares of the medical equipment provider’s stock after selling 94 shares during the quarter. Financial Advocates Investment Management’s holdings in Intuitive Surgical were worth $870,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently made changes to their positions in the stock. M.E. Allison & CO. Inc. bought a new stake in shares of Intuitive Surgical during the 4th quarter valued at $449,000. Seilern Investment Management Ltd purchased a new position in shares of Intuitive Surgical in the fourth quarter valued at about $82,517,000. Exome Asset Management LLC boosted its stake in shares of Intuitive Surgical by 16.8% in the third quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the period. China Universal Asset Management Co. Ltd. grew its position in shares of Intuitive Surgical by 5.6% during the fourth quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares in the last quarter. Finally, Consolidated Planning Corp raised its stake in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock valued at $3,979,000 after purchasing an additional 1,198 shares during the period. 83.64% of the stock is currently owned by institutional investors.

Insider Activity

In related news, insider Jamie Samath sold 269 shares of the stock in a transaction that occurred on Monday, November 11th. The stock was sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 2.98 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 5,940 shares of company stock valued at $3,333,485. 0.90% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of equities research analysts have issued reports on the stock. JPMorgan Chase & Co. increased their price objective on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an “overweight” rating in a report on Friday, January 24th. BTIG Research boosted their price target on shares of Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research note on Tuesday, November 26th. The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research report on Friday, October 18th. Truist Financial boosted their target price on Intuitive Surgical from $640.00 to $666.00 and gave the stock a “buy” rating in a research report on Friday, January 24th. Finally, Royal Bank of Canada lifted their price objective on Intuitive Surgical from $611.00 to $641.00 in a research note on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $613.10.

Intuitive Surgical Stock Down 0.9 %

ISRG opened at $582.98 on Friday. The business has a fifty day moving average of $554.03 and a 200 day moving average of $513.12. Intuitive Surgical, Inc. has a 52-week low of $364.17 and a 52-week high of $616.00. The stock has a market cap of $207.65 billion, a P/E ratio of 90.95, a PEG ratio of 5.51 and a beta of 1.39.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.